1. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? [abstract]. J Rheumatol. 1974. 1:Suppl. 1. 46.
2. Doyle JA, Ginsburg WW. Eosinophilic fasciitis. Med Clin North Am. 1989. 73:1157–1166.
Article
3. Grisanti MW, Moore TL, Osborn TG, Haber PL. Eosinophilic fasciitis in children. Semin Arthritis Rheum. 1989. 19:151–157.
Article
4. Narayanan MN, Liu Yin JA, Love EM, Geary CG, Holt PJ, Freemont AJ, et al. Eosinophilic fasciitis and aplastic anaemia. Clin Lab Haematol. 1988. 10:471–474.
Article
5. Chan LS, Hanson CA, Cooper KD. Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma. Eosinophilic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? Arch Dermatol. 1991. 127:862–865.
Article
6. Castanet J, Lacour JP, Perrin C, Taillan B, Dubois D, Ortonne JP. Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody. Dermatology. 1994. 189:304–307.
Article
7. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988. 17:221–231.
Article
8. Blaser KU, Steiger U, Würsch A, Speck B. Eosinophilic fasciitis with aplastic anemia and Hashimoto's thyroiditis. Review of the literature and report of a typical example. Schweiz Med Wochenschr. 1989. 119:1899–1906.
9. Romero AG, Fernandez JG, Calatayud JC. Eosinophilic fasciitis associated with simple traumatism. Acta Dermatovenerol Croat. 2001. 9:287–290.
10. Buchanan RR, Gordon DA, Muckle TJ, McKenna F, Kraag G. The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy. J Rheumatol. 1980. 7:733–736.
11. Hayashi N, Igarashi A, Matsuyama T, Harada S. Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin. Br J Dermatol. 2000. 142:830–832.
Article
12. Granter SR, Barnhill RL, Duray PH. Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol. 1996. 18:465–473.
Article
13. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature. Dermatology. 2006. 213:93–101.
Article
14. Baumann F, Brühlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D. MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol. 2005. 184:169–174.
Article
15. Fuchs BS, Gordon ML. Lebwohl MG, Heymann WR, Berth-Jones J, Conlson I, editors. Eosinophilic fasciitis. Treatment of skin disease: comprehensive therapeutic strategies. 2006. 2nd ed. London: Mosby;180–182.
16. Weber HO, Schaller M, Metzler G, Röcken M, Berneburg M. Eosinophilic fasciitis and combined UVA1-retinoid-corticosteroid treatment: two case reports. Acta Derm Venereol. 2008. 88:304–306.
17. Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, Nagai Y, et al. Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol. 2007. 26:1445–1451.
Article
18. Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis. Br J Dermatol. 2004. 151:407–412.
Article